• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

近端和远端结直肠癌中染色体不稳定性和错配修复缺陷的进化模式。

Evolutionary patterns of chromosomal instability and mismatch repair deficiency in proximal and distal colorectal cancer.

机构信息

Department of Hematology and Medical Oncology, Comprehensive Cancer Center Augsburg, University Medical Center Augsburg, Augsburg, Germany.

Institute of Pathology, University Medical Center Göttingen, Göttingen, Germany.

出版信息

Colorectal Dis. 2022 Feb;24(2):157-176. doi: 10.1111/codi.15946. Epub 2021 Nov 5.

DOI:10.1111/codi.15946
PMID:34623739
Abstract

AIM

Colorectal carcinomas (CRCs) progress through heterogeneous pathways. The aim of this study was to analyse whether or not the cytogenetic evolution of CRC is linked to tumour site, level of chromosomal imbalance and metastasis.

METHOD

A set of therapy-naïve pT3 CRCs comprising 26 proximal and 49 distal pT3 CRCs was studied by combining immunohistochemistry of mismatch repair (MMR) proteins, microsatellite analyses and molecular karyotyping as well as clinical parameters.

RESULTS

A MMR deficient/microsatellite-unstable (dMMR/MSI-H) status was associated with location of the primary tumour proximal to the splenic flexure, and dMMR/MSI-H tumours presented with significantly lower levels of chromosomal imbalances compared with MMR proficient/microsatellite-stable (pMMR/MSS) tumours. Oncogenetic tree modelling suggested two evolutionary clusters characterized by dMMR/MSI-H and chromosomal instability (CIN), respectively, for both proximal and distal CRCs. In CIN cases, +13q, -18q and +20q were predicted as preferentially early events, and -1p, -4 -and -5q as late events. Separate oncogenetic tree models of proximal and distal cases indicated similar early events independent of tumour site. However, in cases with high CIN defined by more than 10 copy number aberrations, loss of 17p occurred earlier in cytogenetic evolution than in cases showing low to moderate CIN. Differences in the oncogenetic trees were observed for CRCs with lymph node and distant metastasis. Loss of 8p was modelled as an early event in node-positive CRC, while +7p and +8q comprised early events in CRC with distant metastasis.

CONCLUSION

CRCs characterized by CIN follow multiple, interconnected genetic pathways in line with the basic 'Vogelgram' concept proposed for the progression of CRC that places the accumulation of genetic changes at centre of tumour evolution. However, the timing of specific genetic events may favour metastatic potential.

摘要

目的

结直肠癌(CRC)的进展涉及多种途径。本研究旨在分析CRC 的细胞遗传学演变是否与肿瘤部位、染色体失衡程度和转移有关。

方法

通过联合错配修复(MMR)蛋白免疫组化、微卫星分析和分子核型分析以及临床参数,研究了一组未经治疗的 pT3 CRC,包括 26 例近端和 49 例远端 pT3 CRC。

结果

MMR 缺陷/微卫星不稳定(dMMR/MSI-H)状态与脾曲附近的原发肿瘤位置相关,dMMR/MSI-H 肿瘤的染色体失衡程度明显低于 MMR 功能正常/微卫星稳定(pMMR/MSS)肿瘤。肿瘤发生树模型表明,近端和远端 CRC 分别存在两种进化簇,特征分别为 dMMR/MSI-H 和染色体不稳定性(CIN)。在 CIN 病例中,+13q、-18q 和+20q 被预测为早期优先事件,而-1p、-4 和-5q 为晚期事件。近端和远端病例的独立肿瘤发生树模型表明,早期事件与肿瘤部位无关。然而,在具有高 CIN(定义为超过 10 个拷贝数异常)的病例中,与具有低至中度 CIN 的病例相比,染色体进化中较早发生 17p 缺失。在具有淋巴结和远处转移的 CRC 中观察到肿瘤发生树的差异。8p 的缺失被建模为淋巴结阳性 CRC 的早期事件,而+7p 和+8q 包括远处转移的 CRC 的早期事件。

结论

具有 CIN 特征的 CRC 遵循多种相互关联的遗传途径,符合基本的“Vogelgram”概念,该概念将遗传变化的积累置于肿瘤进化的中心。然而,特定遗传事件的时间可能有利于转移潜力。

相似文献

1
Evolutionary patterns of chromosomal instability and mismatch repair deficiency in proximal and distal colorectal cancer.近端和远端结直肠癌中染色体不稳定性和错配修复缺陷的进化模式。
Colorectal Dis. 2022 Feb;24(2):157-176. doi: 10.1111/codi.15946. Epub 2021 Nov 5.
2
Microsatellite instability in mismatch repair proficient colorectal cancer: clinical features and underlying molecular mechanisms.微卫星不稳定在错配修复功能健全的结直肠癌中的临床特征及潜在分子机制。
EBioMedicine. 2024 May;103:105142. doi: 10.1016/j.ebiom.2024.105142. Epub 2024 Apr 30.
3
Deficient mismatch repair/microsatellite unstable colorectal cancer: Diagnosis, prognosis and treatment.错配修复缺陷/微卫星不稳定结直肠肿瘤:诊断、预后和治疗。
Eur J Cancer. 2022 Nov;175:136-157. doi: 10.1016/j.ejca.2022.07.020. Epub 2022 Sep 14.
4
Heterogeneity of Mismatch Repair Status and Microsatellite Instability between Primary Tumour and Metastasis and Its Implications for Immunotherapy in Colorectal Cancers.原发肿瘤与转移灶之间错配修复状态和微卫星不稳定性的异质性及其对结直肠癌免疫治疗的影响。
Int J Mol Sci. 2022 Apr 17;23(8):4427. doi: 10.3390/ijms23084427.
5
Clinicopathological characteristics of high microsatellite instability/mismatch repair-deficient colorectal cancer: A narrative review.高微卫星不稳定性/错配修复缺陷型结直肠癌的临床病理特征:叙述性综述。
Front Immunol. 2022 Dec 23;13:1019582. doi: 10.3389/fimmu.2022.1019582. eCollection 2022.
6
Discordant prognosis of mismatch repair deficiency in colorectal and endometrial cancer reflects variation in antitumour immune response and immune escape.结直肠癌和子宫内膜癌中错配修复缺陷的预后不一致反映了抗肿瘤免疫反应和免疫逃逸的差异。
J Pathol. 2022 Jul;257(3):340-351. doi: 10.1002/path.5894. Epub 2022 Apr 1.
7
Morphological, immunophenotypical and molecular features of hypermutation in colorectal carcinomas with mutations in DNA polymerase ε (POLE).DNA 聚合酶 ε(POLE)基因突变的结直肠癌中超突变的形态学、免疫表型和分子特征。
Histopathology. 2020 Feb;76(3):366-374. doi: 10.1111/his.13984. Epub 2019 Dec 1.
8
Clinicopathological features of mismatch repair protein expression patterns in colorectal cancer.结直肠癌错配修复蛋白表达模式的临床病理特征。
Pathol Res Pract. 2021 Jan;217:153288. doi: 10.1016/j.prp.2020.153288. Epub 2020 Nov 16.
9
SH2D4A downregulation due to loss of chromosome 8p is associated with poor prognosis and low T cell infiltration in colorectal cancer.SH2D4A 下调由于 8p 染色体缺失与结直肠癌不良预后和低 T 细胞浸润有关。
Br J Cancer. 2022 Apr;126(6):917-926. doi: 10.1038/s41416-021-01660-y. Epub 2021 Dec 10.
10
Immunotherapy efficacy on mismatch repair-deficient colorectal cancer: From bench to bedside.免疫疗法对错配修复缺陷型结直肠癌的疗效:从基础到临床。
Biochim Biophys Acta Rev Cancer. 2020 Dec;1874(2):188447. doi: 10.1016/j.bbcan.2020.188447. Epub 2020 Oct 6.

引用本文的文献

1
Exploring potential therapeutic targets for colorectal tumors based on whole genome sequencing of colorectal tumors and paracancerous tissues.基于结直肠癌及癌旁组织全基因组测序探索结直肠癌潜在治疗靶点
Front Mol Biosci. 2025 Jul 4;12:1605117. doi: 10.3389/fmolb.2025.1605117. eCollection 2025.
2
Tumor associated chromosomal instability drives colorectal adenoma to adenocarcinoma progression based on 17 year follow up evidence.基于17年随访证据,肿瘤相关染色体不稳定性驱动结直肠腺瘤进展为腺癌。
Sci Rep. 2025 Apr 21;15(1):13733. doi: 10.1038/s41598-025-96921-8.
3
Cytogenetic signatures favoring metastatic organotropism in colorectal cancer.
支持结直肠癌转移器官趋向性的细胞遗传学特征
Nat Commun. 2025 Apr 5;16(1):3261. doi: 10.1038/s41467-025-58413-1.
4
Deletion of 17p in cancers: Guilt by (p53) association.癌症中17号染色体短臂缺失:因(p53)关联而获罪。
Oncogene. 2025 Mar;44(10):637-651. doi: 10.1038/s41388-025-03300-8. Epub 2025 Feb 18.
5
Chromosomal instability: a key driver in glioma pathogenesis and progression.染色体不稳定性:胶质母细胞瘤发病机制和进展的关键驱动因素。
Eur J Med Res. 2024 Sep 4;29(1):451. doi: 10.1186/s40001-024-02043-8.
6
Measuring cancer driving force of chromosomal aberrations through multi-layer Boolean implication networks.通过多层布尔蕴涵网络测量染色体畸变的癌症驱动力。
PLoS One. 2024 Apr 9;19(4):e0301591. doi: 10.1371/journal.pone.0301591. eCollection 2024.
7
Greasing the Wheels of Pharmacotherapy for Colorectal Cancer: the Role of Natural Polyphenols.为结直肠癌的药物治疗提供助力:天然多酚的作用。
Curr Nutr Rep. 2023 Dec;12(4):662-678. doi: 10.1007/s13668-023-00512-w. Epub 2023 Dec 2.
8
SNP array genomic analysis of matched pairs of brain and liver metastases in primary colorectal cancer.对原发性结直肠癌脑转移和肝转移配对组织的 SNP 芯片基因组分析。
J Cancer Res Clin Oncol. 2023 Dec;149(20):18173-18183. doi: 10.1007/s00432-023-05505-4. Epub 2023 Nov 27.
9
Very Unstable Genetics: How the Confluence of Microsatellite Instability and Immunotherapy Revolutionized the Treatment of Colon Cancer.极不稳定的遗传学:微卫星不稳定性与免疫疗法的融合如何彻底改变了结肠癌的治疗
Dig Dis Sci. 2023 Sep;68(9):3494-3503. doi: 10.1007/s10620-023-08007-y. Epub 2023 Jul 5.
10
Systemic treatment for metastatic colorectal cancer.转移性结直肠癌的系统治疗。
World J Gastroenterol. 2023 Mar 14;29(10):1569-1588. doi: 10.3748/wjg.v29.i10.1569.